IT-thumbnail.png

AI Oncology Tools Market Research Report - Size, Share, Growth, and Trend Analysis | Forecast (2025 - 2030)

AI Oncology Tools Market (2025-2030)

What are AI Oncology Tools?

AI Oncology refers to the application of artificial intelligence in cancer detection, treatment, and drug development. By leveraging machine learning, deep learning, and other AI techniques, it helps optimize cancer diagnostics, improve personalized treatment plans, and accelerate clinical trials. AI tools analyze large datasets, including genomic information and medical imaging, to uncover insights that would be difficult or time-consuming for humans to detect.

The disruptive impact of AI Oncology is profound, offering the ability to analyze massive volumes of data, which could lead to faster, more accurate diagnoses and better treatment outcomes. The opportunities in this field are new and big, providing easy access to data-driven insights and safer, more effective therapeutic solutions for cancer patients.

Key Market Players:

  • ImmuneAI
  • iBio
  • Evaxion Biotech
  • Lantern Pharma
  • Predictive Oncology

Case Study:

Lantern Pharma uses AI to identify promising cancer therapies, dramatically speeding up drug discovery and offering more targeted treatments.

Popularity and Key Statistics:

  • Demand for AI-driven cancer treatments is rising, with increasing investments in AI oncology solutions.
  • Hospitals and cancer centers are rapidly adopting AI tools to enhance diagnostic accuracy and treatment efficacy.

Market Segmentation:

  • By Type
    • AI-based Diagnostics
      • Imaging-based Diagnostics
      • Biomarker-based Diagnostics
    • AI-based Therapeutics
      • Drug Discovery
      • Personalized Medicine
    • AI-based Clinical Trials
      • Patient Recruitment
      • Trial Monitoring
    • AI-based Decision Support Systems
      • Treatment Recommendations
      • Prognostic Models
    • AI-based Surgical Assistance
      • Robotic Surgery
      • Preoperative Planning
  • By End User
    • Hospitals
      • Cancer Centers
      • Oncology Departments
    • Pharmaceutical Companies
      • Drug Developers
      • Biotech Firms
    • Research Institutes
      • Academic Institutions
      • Cancer Research Organizations
    • Diagnostic Laboratories
      • Imaging Labs
      • Pathology Labs
    • Healthcare Providers
      • Oncologists
      • General Practitioners

What’s in it for you?

  • Gain insights into the latest advancements in AI oncology.
  • Understand key market trends and future growth opportunities.
  • Identify strategic players and potential partnerships for market expansion.

 

 

 

 

 

Chapter 1. Global AI Oncology Tools Market– Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Global AI Oncology Tools Market– Executive Summary
2.1    Market Size & Forecast – (2025 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
         2.2.1    Demand Side
         2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis
Chapter 3. Global AI Oncology Tools Market– Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis
Chapter 4. Global AI Oncology Tools Market Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
         4.5.1    Bargaining Power of Suppliers
         4.5.2    Bargaining Powers of Customers
         4.5.3    Threat of New Entrants
         4.5.4    Rivalry among Existing Players
         4.5.5    Threat of Substitutes
Chapter 5. Global AI Oncology Tools Market– Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities
Chapter 6. Global AI Oncology Tools Market– By Type 
6.1    Introduction/Key Findings   
6.2    AI-based Diagnostics 
         6.2.1    Imaging-based Diagnostics
         6.2.2    Biomarker-based Diagnostics
6.3    AI-based Therapeutics 
         6.3.1    Drug Discovery
         6.3.2    Personalized Medicine
6.4    AI-based Clinical Trials 
         6.4.1    Patient Recruitment
         6.4.2    Trial Monitoring
6.5    AI-based Decision Support Systems 
         6.5.1    Treatment Recommendations
         6.5.2    Prognostic Models
6.6    AI-based Surgical Assistance 
         6.6.1    Robotic Surgery
6.7    Preoperative Planning
6.8    Y-O-Y Growth trend Analysis By Type 
6.9    Absolute $ Opportunity Analysis By Type , 2025-2030
 
Chapter 7. Global AI Oncology Tools Market– By End User 
7.1    Introduction/Key Findings   
7.2    Hospitals 
         7.2.1    Cancer Centers
         7.2.2    Oncology Departments
7.3    Pharmaceutical Companies 
         7.3.1    Drug Developers
         7.3.2    Biotech Firms
7.4    Research Institutes 
         7.4.1    Academic Institutions
         7.4.2    Cancer Research Organizations
7.5    Diagnostic Laboratories 
         7.5.1    Imaging Labs
         7.5.2    Pathology Labs
7.6    Healthcare Providers 
         7.6.1    Oncologists
         7.6.2    General Practitioners
7.7    Y-O-Y Growth  trend Analysis By End User 
7.8    Absolute $ Opportunity Analysis By End User , 2025-2030
      
Chapter 8. Global AI Oncology Tools Market, By Geography – Market Size, Forecast, Trends & Insights
8.1. North America
                                8.1.1. By Country
                                                8.1.1.1. U.S.A.
                                                8.1.1.2. Canada 
                                                8.1.1.3. Mexico
                                8.1.2. By End User  
                                8.1.3. By Type 
                                8.1.4. Countries & Segments - Market Attractiveness Analysis
   8.2. Europe
                                8.2.1. By Country
                                                8.2.1.1. U.K.                         
                                                8.2.1.2. Germany
                                                8.2.1.3. France
                                                8.2.1.4. Italy
                                                8.2.1.5. Spain
                                                8.2.1.6. Rest of Europe
                                8.2.2. By End User  
                                8.2.3. By Type 
                                8.2.4. Countries & Segments - Market Attractiveness Analysis
8.3. Asia Pacific
                                8.3.1. By Country
                                                8.3.1.1. China
                                                8.3.1.2. Japan
                                                8.3.1.3. South Korea
                                                8.3.1.4. India      
                                                8.3.1.5. Australia & New Zealand
                                                8.3.1.6. Rest of Asia-Pacific
                                8.3.2. By End User  
                                8.3.3. By Type 
                                8.3.4. Countries & Segments - Market Attractiveness Analysis
8.4. South America
                                8.4.1. By Country
                                                8.4.1.1. Brazil
                                                8.4.1.2. Argentina
                                                8.4.1.3. Colombia
                                                8.4.1.4. Chile
                                                8.4.1.5. Rest of South America
                                8.4.2.  By End User  
                                8.4.3. By Type 
                                8.4.4. Countries & Segments - Market Attractiveness Analysis
8.5. Middle East & Africa
                                8.5.1. By Country
                                                8.5.1.1. United Arab Emirates (UAE)
                                                8.5.1.2. Saudi Arabia
                                                8.5.1.3. Qatar
                                                8.5.1.4. Israel
                                                8.5.1.5. South Africa
                                                8.5.1.6. Nigeria
                                                8.5.1.7. Kenya
                                                8.5.1.8. Egypt
                                                8.5.1.8. Rest of MEA
                              8.5.2. By End User  
                             8.5.3. By Type 
                             8.5.4. Countries & Segments - Market Attractiveness Analysis
Chapter 9. Global AI Oncology Tools Market– Company Profiles – (Overview, Type Portfolio, Financials, Strategies & Developments)
9.1    ImmuneAI
9.2    iBio
9.3    Evaxion Biotech
9.4    Lantern Pharma
9.5    Predictive Oncology


 

Download Sample

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Analyst Support

Every order comes with Analyst Support.

Customization

We offer customization to cater your needs to fullest.

Verified Analysis

We value integrity, quality and authenticity the most.